Zeyad Morcos. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntirheumatic Agents/adverse effectsAntirheumatic Agents/therapeutic useAutoantibodiesHumansInfliximabNervous System Diseases/drug therapyNervous System Diseases/etiologySarcoidosis/complicationsSarcoidosis/drug therapyTreatment OutcomeTuberculosis/chemically induced
Substances: See more » Antibodies, MonoclonalAntirheumatic AgentsAutoantibodiesInfliximab
Year: 2003 PMID: 12682347 DOI: 10.1212/wnl.60.7.1220-a
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910